Merck & Co. is negotiating with the Thai government to supply 200,000 courses of an experimental antiviral drug for the coronavirus. The company is also in talks to supply the drug with the governments of South Korea, Taiwan and Malaysia. All of the participants declined to provide details of the negotiations.